Please note our Leading an Empowered Organisation™ (LEO) programme is a development opportunity for nursing, midwifery and allied health professional (NMAHP) staff working at Newcastle Hospitals only
This course describes how bowel cancer comes about, and explains the reasons why some patients might be given treatments such as EGFR-targeted antibodies (cetuximab and panitumumab), angiogenesis inhibitors (bevacizumab and regorafenib), or immune checkpoint inhibitors (pembrolizumab) as part of their treatment.
The 4Ps Programme has been developed by research active healthcare professionals in Newcastle and is designed to support colleagues' needs no matter where they are on the “research interested” to “Aspiring Clinical Academic” continuum
Please note our Leading an Empowered Organisation™ (LEO) programme is a development opportunity for nursing, midwifery and allied health professional (NMAHP) staff working at Newcastle Hospitals only
This course provides an overview of the targeted therapies and immunotherapies given to some people with oesophageal, stomach, pancreatic or liver cancer, or cancers of the biliary system
Please note our Leading an Empowered Organisation™ (LEO) programme is a development opportunity for nursing, midwifery and allied health professional (NMAHP) staff working at Newcastle Hospitals only
Join leading experts and frontline professionals for a one-day deep dive into the latest developments challenges, treatments and strategies in paediatric respiratory medicine.
This two-day course will teach the different methods of wound debridement, with a special focus on conservative sharp debridement, facilitated by the Newcastle Hospitals’ Tissue Viability Team with guest speaker specialists from Dermatology, Plastics, Podiatry as well as a physiology and anatomical expert.
This course explains why breast cancer arises, the different ways that the DNA in our cells gets damaged and the targeted treatments that match a few of the known mutations. It also explores the science behind hormone therapies, targeted therapies, and immunotherapies given to patients with hormone receptor-positive, HER2-positive, and triple-negative breast cancer.
A unique Specialist Consultant taught interactive educational experience for the referring and reporting of Cone Beam CT. Validated by the Royal College of Physicians and Surgeons (Glasgow) in order to match the recommended hours for Level 2 reporting.
Our Laser Protection Supervisor (LPS) Training encompasses the fundamental principles of laser safety. We combine self-paced learning materials with practical scenario-based teaching. This course aims to provide you with the appropriate knowledge and confidence to fulfil your duties as an LPS in your workplace.
Haematological cancers differ from solid tumours in many ways: in the mutations that drive them, their interactions with their environment, and the treatments that are effective against them. This course introduces the biology, behaviours and genetics of this diverse group of diseases with a focus on the features we can now target and the mechanisms of action of the various treatments